Dr. Meera Narasimhan, M.D

NPI: 1235199233
Total Payments
$57,045
2023 Payments
$400.00
Companies
2
Transactions
32

Payment Breakdown by Category

Consulting$55,520 (97.3%)
Travel$1,164 (2.0%)
Food & Beverage$361.55 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $55,520 25 97.3%
Travel and Lodging $1,164 2 2.0%
Food and Beverage $361.55 5 0.6%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $56,645 31 $0 (2022)
Janssen Scientific Affairs, LLC $400.00 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $400.00 1 Janssen Scientific Affairs, LLC ($400.00)
2022 $7,780 6 Alkermes, Inc. ($7,780)
2021 $16,800 10 Alkermes, Inc. ($16,800)
2020 $23,040 7 Alkermes, Inc. ($23,040)
2019 $9,025 8 Alkermes, Inc. ($9,025)

All Payment Transactions

32 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
04/03/2023 Janssen Scientific Affairs, LLC INVEGA SUSTENNA (Drug), INVEGA TRINZA Consulting Fee Cash or cash equivalent $400.00 General
Category: Neuroscience
12/05/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,000.00 General
Category: CNS
12/05/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,880.00 General
Category: CNS
12/05/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,260.00 General
Category: CNS
12/05/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $520.00 General
Category: CNS
12/05/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $120.00 General
Category: CNS
11/21/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,000.00 General
Category: CNS
11/15/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,260.00 General
Category: CNS
11/01/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,100.00 General
Category: CNS
11/01/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,100.00 General
Category: CNS
11/01/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,100.00 General
Category: CNS
11/01/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,100.00 General
Category: CNS
11/01/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,260.00 General
Category: CNS
10/12/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,100.00 General
Category: CNS
10/12/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,260.00 General
Category: CNS
04/20/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,160.00 General
Category: CNS
04/20/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $360.00 General
Category: CNS
12/01/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,520.00 General
Category: CNS
11/09/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,920.00 General
Category: CNS
11/09/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $600.00 General
Category: CNS
09/28/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,600.00 General
Category: CNS
09/08/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $2,000.00 General
Category: CNS
06/15/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $1,600.00 General
Category: CNS
04/27/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $12,800.00 General
Category: CNS
04/22/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $7,500.00 General
Category: CNS

About Dr. Meera Narasimhan, M.D

Dr. Meera Narasimhan, M.D is a Psychiatry healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235199233.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meera Narasimhan, M.D has received a total of $57,045 in payments from pharmaceutical and medical device companies, with $400.00 received in 2023. These payments were reported across 32 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($55,520).

Practice Information

  • Specialty Psychiatry
  • Location Columbia, SC
  • Active Since 03/24/2006
  • Last Updated 03/16/2020
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1235199233

Products in Payments

  • ARISTADA (Drug) $56,645
  • INVEGA SUSTENNA (Drug) $400.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Columbia